Cormedix (NASDAQ:CRMD) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Cormedix beat estimated earnings by 18.18%, reporting an EPS of $-0.18 versus an estimate of $-0.22.
Revenue was down $80.62 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 5.6% increase in the share price the next day.
Here’s a look at Cormedix’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.23 | -0.18 | -0.17 | -0.18 |
| EPS Actual | -0.20 | -0.22 | -0.12 | -0.20 |
| Revenue Estimate | 20.00K | 20.00K | 40.00K | 140.00K |
| Revenue Actual | 56.40K | 38.09K | 8.19K | 88.26K |
To track all earnings releases for Cormedix visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
